Background The use of rosuvastatin plus colchicine and emtricitabine/tenofovir in
hospitalized patients with SARS-CoV-2 disease (COVID-19) has not been assessed. The …

Objective To evaluate the effect of colchicine and high-intensity rosuvastatin in addition to
standard of care on the progression of COVID-19 disease in hospitalised patients. Design A …

Introduction Efficacious therapies are urgently required to tackle the coronavirus disease
2019 (COVID-19). This trial aims to evaluate the effects of atorvastatin in comparison with …

Purpose Considering the anti‐inflammatory effect of atorvastatin and the role of medical
comorbidities such as hypertension and coronary artery disease on the prognosis of the …

This systematic review and meta‐analysis aimed to determine the efficacy of statins in
hospitalized patients with coronavirus disease‐2019 (COVID‐19). A systematic search was …

Background The efficacy of simvastatin in critically ill patients with coronavirus disease 2019
(Covid-19) is unclear. Methods In an ongoing international, multifactorial, adaptive platform …

Background: Statins are first-line lipid-lowering agents with tolerable adverse reactions, low
cost, and high availability worldwide. The potent anti-inflammatory, antioxidant, anti …

Objectives To assess the impact of adding statin (atorvastatin) and/or aspirin on clinical
deterioration in patients infected with SARS-CoV-2 who require hospitalisation. The safety of …

Background Statins and aspirin have been proposed for treatment of COVID-19 because of
their anti-inflammatory and anti-thrombotic properties. Several observational studies have …

There is mounting evidence that statin use is beneficial for COVID-19 outcomes. We
performed a systematic review and meta-analysis to evaluate the association between statin …